1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Fogarty Emerging Global Leader Award (K43 Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH), Fogarty International Center (FIC). This award provides research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country (LMIC) who holds a junior faculty position at an LMIC academic or research institution.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Emerging Global Leader Award (K43) - Fogarty International Center @ NIH NIH Websites Are Changing Get the Latest Updates and FAQs Emerging Global Leader Award Emerging Global Leader Award (K43 Independent Clinical Trial Required) (PAR-24-295) Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) (PAR-24-296) Only low- or middle-income country (LMIC) institutions are eligible.
Income categories are defined by The World Bank Country and Lending Groups . Country eligibility for Fogarty International Training Grants applies.
Eligibility for applications with Independent Clinical Trials (PAR-24-295) Eligibility for applications without Independent Clinical Trials (PAR-24-296) Answers to frequently asked questions (FAQs) The Fogarty Emerging Global Leader Award aims to provide research support and protected time to a research scientist from a LMIC who holds an academic junior faculty position or research scientist appointment at an LMIC academic or research institution.
Low-income, lower-middle-income and upper-middle-income countries are included. Applications are invited from LMIC research scientists from any health-related discipline who propose both critically needed career development activities and a research project that is highly relevant to the health priorities of their country. View a list of Emerging Global Leader awards by institution.
Fogarty International Center National Institutes of Health Grants Management Specialist Fogarty International Center National Institutes of Health 31 Center Drive, MSC 2220 This announcement is issued by Fogarty in collaboration with the following NIH Institutes and Centers: National Cancer Institute (NCI) National Eye Institute (NEI) National Human Genome Research Institute (NHGRI) National Heart, Lung, and Blood Institute (NHLBI) National Institute on Aging (NIA) National Institute on Drug Abuse (NIDA) National Institute on Deafness and Other Communication Disorders (NIDCD) National Institute on Dental and Craniofacial Research (NIDCR) National Institute of Environmental Health Sciences (NIEHS) National Institute of Mental Health (NIMH) National Institute of Neurological Disorders and Stroke (NINDS) NIH Office of Research on Women's Health (ORWH) Grant recipient news: Celebrating our emerging global leaders in health sciences University of Cape Town news, September 9, 2024 Hepatitis B surface antigen loss in individuals with chronic hepatitis B virus and HIV-1 infections in Botswana , co-authored by Fogarty grant recipients Roger Shapiro, Joseph Makhema, and Shahin Lockman, Fogarty Emerging Global Leader Sikhulile Moyo, and Fogarty trainees Mompati Mmalane and Simani Gaseitsiwe Gaps and Opportunities for Strengthening In-School Support for Youth Living With HIV , co-authored by Fogarty Emerging Global Leader Irene Njuguna The Journal of School Health , February 2024 Defining the usefulness of oral swabs in tuberculosis diagnosis , co-authored by Fogarty Emerging Global Leader Marieke M.
van Der Zalm The Lancet Global Health , January 1, 2024 Podcast: Improving Access to Vaccines in Children , featuring Fogarty Emerging Global Leader Oghenebrume Wariri ImmunoAfrica podcast, January 28, 2024 Utilization of opportunistic cervical cancer screening in Nigeria , co-authored by Fogarty Emerging Global Leader Jonah Musa Cancer Causes and Control , January 2024 Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in Botswana , co-authored by Fogarty grantees Joseph Makhema, Roger Shapiro, and Shahin Lockman, Fogarty Emerging Global Health Leader Sikhulile Moyo, and Fogarty trainees Ontlametse Bareng, Terence Mohammed, and Catherine Koofhethile Scientific Reports , October 24, 2023 Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use , co-authored by Fogarty Emerging Global Leader Sikhulile Moyo, Fogarty grant recipients Joseph Makhema, Roger Shapiro, and Shahin Lockman, and Fogarty trainees Ontlametse Bareng, Patrick Mokgethi, Kaelo Seatla, Catherine Koofhethille, and Simani Gaseitsiwe The Journal of Antimicrobial Chemotherapy , October 3, 2023 This researcher wants to normalize mental health care in Ukraine Global Health Matters , September/October 2023 Dr. Anthony Batte wins the NIH Emerging Global Leaders Award Makerere University news, August 29, 2023 Clinical Presentation and Outcome of Acute Respiratory Illnesses in South African Children During the COVID-19 Pandemic , co-authored by Emerging Global Leader Marieke Van Der Zalm Pediatric Infectious Disease Journal , August 2023 Vaginal microbiome community state types and high-risk human papillomaviruses in cervical precancer and cancer in North-central Nigeria , co-authored Emerging Global Leader John Musa BMC Cancer , July 20, 2023 Human testing for potential new TB treatment, first in nearly six decades profile of Fogarty Emerging Global Leader Admire Dube, Nature Africa , June 27, 2023 Employing user-centered design to fill gaps in mental health treatment : Q&A with Emerging Global Leader Lola Kola Global Health Matters , Nov/Dec 2022 Oral health researchers welcome here!
– Opinion by Fogarty Director Dr. Roger I.
Glass Emerging and re-emerging fungal threats in Africa , Fogarty grantee Sean Wasserman co-author Parasite Immunology , September 29, 2022 Emerging Global Leader/Fogarty Fellow Dr. Siana Nkya tackles sickle cell disease in Tanzania Global Health Matters , May/June 2022 Dr. Veronica Dzomeku hopes to transform maternity care in Ghana Global Health Matters , Nov/Dec 2021 Emerging Global Leader/NCI grantee Dr Simone Badal addresses inequities in prostate cancer Grantee spotlight: Dr Simone Badal Novel prostate cancer cell lines to address prostate cancer disparity in Black men Spotlight blog, May 27, 2021 Fogarty allocates $4M to support early-career scientists Emerging Global Leader grantee Dr Manasi Kumar studies COVID impact on pregnant teens in Kenya Fogarty awards $10M for early-career researchers to establish independent careers in global health Dr Leopold Tientcheu Djomkam wins the K43 Emerging Global Leader Award MRC Unit The Gambia/LSTMH news, Oct 2018 Stopping malnutrition in its tracks Aga Khan University news, Nov 27, 2017 Emerging global health leaders receive $5M in research support Fogarty news, November 16, 2017 NIH awards $3M to support emerging research leaders in developing countries Fogarty news, August 4, 2016 Career Award (K) Policy Update: Concurrent Support from a Mentored K Award and a Research Grant (NOT-OD-18-157) , released April 6, 2018 Notice of NIDCD Participation in PAR-21-251 "Emerging Global Leader Award (K43 Independent Clinical Trial Required)" and PAR-21-252 “Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)” (NOT-DC-23-007) , released April 6, 2023 Notice of letter of intent guidance for PAR-19-098 and PAR-19-051 ( NOT-TW-19-001 ), released January 11, 2019
According to the current listing, eligibility includes: Non-domestic (non-U. S.) Entities (Foreign Institutions) in Low- or Middle-Income Countries (LMICs) are eligible to apply. Academic education or research institutions in LMICs are eligible. Confirm the full requirements in the official notice before applying.
Applications for Fogarty Emerging Global Leader Award (K43 Clinical Trial Not Allowed) are due December 3, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Fogarty Emerging Global Leader Award (K43 Clinical Trial Not Allowed) is funded by National Institutes of Health (NIH), Fogarty International Center (FIC). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article